Our news

  • Latest episode of the Dementia Researcher podcast chats about the work of Cochrane, how we support evidence-informed decision making in healthcare, our work on undertaking systematic reviews, and how you could become involved.The Cochrane Dementia and Cognitive Improvement Group create reviews and methods...
    June 7 2021
  • In this author interview we find out more about this recently published Network Meta-analysis, New generation antidepressants for depression in children and adolescents. Authors Dr. Sarah Hetrick and Nick Meader tell us about this work.What were you trying to find out with this Network Meta-Analysis?We were trying to find out how well...
    May 25 2021
  • Updated review: Internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder (PTSD) in adultsWhy was this review important?Post-traumatic stress disorder, or PTSD, is a common mental illness that can occur after a serious traumatic event. Symptoms include re-experiencing the trauma as nightmares, flashbacks, and...
    May 20 2021
  • In this author interview, lead authors Nick Meader and Andrew Moriarity tell us about this recently published Cochrane review, how they worked with a patient advisory group, and how they rose to the challenge of this being their first prognostic review, and the first of this type for Cochrane Common Mental Disorders.Nick Meader: ...
    May 6 2021
  • In this recently published Cochrane review, the author team explored whether taking a certain type of medication could make older people more likely to develop dementia. Discussing the review, Terry Quinn, senior author, said: "Almost every week we see a newspaper headline describing something new that allegedly causes or protects...
    May 6 2021
  • Antidepressants are widely used for depression and anxiety. Guidelines recommend that an antidepressant should be continued for at least six months after people start to feel better, and for at least two years if they have had two or more periods of depression. Many people take antidepressants for much longer. Ellen Van Leeuwen and Mark Horowitz,...
    April 22 2021
  • How well does behavioural activation therapy work for depression in adults?  And what about the effects of this treatment on depression for adults with long‐term physical conditions? Two Cochrane systematic reviews look at the available evidence.Depression is a common mental health problem. It can cause a persistent feeling of sadness and...
    January 22 2021
  • Drugs and natural products for self‐harm in adultsThe authors have reviewed the international literature regarding pharmacological (drug) and natural product (dietary supplementation) treatment trials in the field. A total of seven trials that met inclusion criteria were identified. There is little evidence of beneficial effects of either...
    January 14 2021
  • In this short interview, Postdoctoral Researcher and lead author Tessa Reardon tells us about this recently published review. What does this Cochrane review tell us about the role of cognitive behavioural therapy for anxiety disorders in children and adolescents?Our review shows the key role cognitive behaviour therapy (CBT) plays in the...
    December 7 2020
  • Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System recently launched an international priority setting exercise. Here, the Co-ordinating Editors, Dr Graziella Filippini and Dr Francesco Nonino, tell us about their experience with priority setting and plans for evaluation and implementation. Why do you think it’s...
    December 7 2020

Pages

Subscribe to Our news